INCY.NASDAQIncyte CORP

Form 4: Incyte EVP Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


Incyte's EVP & General Counsel, Sheila A. Denton, reported exercising stock options and subsequently selling shares, including shares withheld for tax obligations, under a Rule 10b5-1 plan.

Summary

  • Sheila A. Denton, Executive Vice President & General Counsel of Incyte Corp (INCY), reported multiple transactions involving the company's common stock.
  • On October 2, 2025, Denton exercised employee stock options to acquire 599 shares of common stock at an exercise price of $58.06 per share.
  • Concurrently on October 2, 2025, 599 shares were sold at $87.65 per share.
  • Also on October 2, 2025, 3,130 shares were withheld by Incyte Corp at $86.28 per share to satisfy tax withholding obligations related to previously reported restricted stock units.
  • On October 3, 2025, an additional 3,501 shares of common stock were sold at $85.54 per share.
  • Following these transactions, Denton's direct beneficial ownership of common stock decreased from 33,799 shares to 26,569 shares.
  • The remaining beneficial ownership of 26,569 shares includes an aggregate of 25,913 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not yet vested.
  • The employee stock options exercised on October 2, 2025, began vesting on October 2, 2023, with the first 25% vesting on October 2, 2024, and the remainder vesting monthly over three years, with an expiration date of October 2, 2033.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there is insider selling, it is pre-planned under a 10b5-1 plan, which mitigates concerns about opportunistic selling. The executive also exercised options, realizing value from their compensation.

Positives

  • The exercise of employee stock options indicates the executive is realizing value from previously granted equity compensation.
  • The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan, indicating pre-scheduled sales and reducing concerns about opportunistic insider selling.

Negatives

  • The net effect of the reported transactions was a reduction in the executive's direct beneficial ownership of common stock by 7,230 shares (from 33,799 to 26,569 shares).
  • Insider selling, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the executive's direct equity stake in the company.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report (Form 4) and does not provide information directly related to broader industry trends or competitive landscape. It reflects an executive's personal equity management.

Related Party Transactions

  • Sheila A. Denton, EVP & General Counsel of Incyte Corp, engaged in transactions involving the company's common stock, which are considered related party transactions due to her executive position.

Stakeholder Impact

  • Shareholders: The sale of shares by an executive slightly reduces their direct equity alignment with shareholders, though the pre-planned nature under Rule 10b5-1 lessens potential negative interpretations.
  • Employees: The transactions are part of executive compensation and equity management, which is a standard practice for senior leadership.

Key Dates

DateDescription
10/02/2023Employee stock options began vesting in 37 installments.
10/02/2024First 25% of employee stock options vested.
10/02/2025Date of employee stock option exercise, common stock sale, and tax withholding transactions.
10/03/2025Date of additional common stock sale transaction.
10/06/2025Date the Statement of Changes in Beneficial Ownership (Form 4) was signed.
10/02/2033Expiration date of the employee stock options.

Keywords

Incyte Corp, INCY, Form 4, Insider Transaction, Stock Options, Executive Compensation, Share Sale, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.